Badger Meter (BMI) Rises Higher Than Market: Key Facts

Badger Meter (BMI) recently closed up 1.74% at $179.75, outperforming the broader market for the day, though its shares declined 2.8% over the past month. The company is projected to report Q1 EPS of $1.11 (+2.78% YoY) and revenue of $229.36 million (+10.04% YoY), with full fiscal year estimates also indicating double-digit growth. Despite these growth expectations, recent analyst EPS estimates have seen a 0.55% downward revision, contributing to its Zacks Rank #3 (Hold) and a premium Forward P/E of 37.64 compared to the industry average of 28.24.

Analysis

Badger Meter (BMI) exhibited short-term strength, closing at $179.75 with a 1.74% gain that outpaced the S&P 500. However, this follows a period of relative weakness, with the stock declining 2.8% over the past month, significantly underperforming both the S&P 500's 3.94% gain and its own sector's 8.78% gain. Forward-looking consensus estimates remain robust, projecting 10.04% year-over-year revenue growth for the upcoming quarter and double-digit growth for the full fiscal year. Despite this positive outlook, a key cautionary signal is the 0.55% downward revision in the consensus EPS estimate over the past month, which contributes to the current Zacks Rank of #3 (Hold). The stock's valuation is a critical factor, trading at a significant premium with a Forward P/E of 37.64, compared to the industry average of 28.24. While its PEG ratio of 3.13 is in line with the industry, it suggests the market has already priced in strong future growth, leaving little room for execution missteps.

Key Decisions for Investors

• Given the stock's premium valuation and reliance on future growth, investors should scrutinize the upcoming earnings report for any signs that the company may not meet its projected 10.04% quarterly revenue growth, as a miss could lead to a valuation reset.
• The conflict between strong full-year growth forecasts and the recent downward revision of near-term EPS estimates warrants a cautious stance; it may be prudent to await the upcoming financial results for clarity on business trends before initiating or adding to a position.
• Investors should monitor for management commentary explaining the recent 2.8% monthly stock underperformance, especially in the context of a strongly performing sector, as this could reveal company-specific challenges not yet priced into consensus estimates.